Theodore James Jr. Washburn - Feb 14, 2023 Form 4 Insider Report for AGIOS PHARMACEUTICALS, INC. (AGIO)

Role
Principal Accounting Officer
Signature
/s/ William Cook, as attorney-in-fact for Theodore James Jr. Washburn
Stock symbol
AGIO
Transactions as of
Feb 14, 2023
Transactions value $
-$18,081
Form type
4
Date filed
2/16/2023, 03:04 PM
Previous filing
Feb 14, 2023
Next filing
Feb 21, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AGIO Common stock Options Exercise $0 +360 +11.35% $0.00 3.53K Feb 14, 2023 Direct
transaction AGIO Common stock Tax liability -$3.67K -127 -3.6% $28.91 3.41K Feb 14, 2023 Direct
transaction AGIO Common stock Sale -$14.4K -504 -14.8% $28.59 2.9K Feb 14, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AGIO Restricted stock units Options Exercise $0 -360 -100% $0.00* 0 Feb 14, 2023 Common stock 360 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
F2 Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.
F3 The restricted stock units were granted on February 14, 2020. Beginning on February 14, 2021, the shares underlying the restricted stock units will vest in three equal annual installments.